• Rimonabant (SR141716): Precision in Appetite Regulation Rese

  2026-07-15

  Rimonabant (SR141716) empowers researchers to dissect the endocannabinoid system with high CB1 selectivity, offering reproducible control over appetite and energy balance in both in vitro and in vivo models. This article details advanced workflows, protocol optimizations, and troubleshooting strategies that set SR141716 apart for obesity and neurobiology research.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Mecha

  2026-07-15

  The referenced study establishes moesin (MSN) as a critical biomarker of endothelial injury in sepsis, linking its serum levels with disease severity. By dissecting the mechanistic pathways, the research advances our understanding of vascular dysfunction in sepsis and highlights new avenues for biomarker-driven evaluation.

• NHS-Biotin Workflows for Robust Protein Labeling & Purificat

  2026-07-14

  NHS-Biotin’s amine-reactivity and membrane permeability unlock precise, stable protein labeling for detection, purification, and advanced engineering. Discover protocol optimizations, troubleshooting strategies, and key innovations inspired by recent multimeric nanobody research.

• PPACK Dihydrochloride: Precision Thrombin Inhibition Workflo

  2026-07-14

  PPACK Dihydrochloride stands out as an irreversible, high-affinity thrombin inhibitor, streamlining platelet aggregation and blood coagulation research with unmatched specificity. This article breaks down validated workflows, advanced troubleshooting, and the latest innovations, empowering researchers to achieve reproducible, high-fidelity results in even the most challenging coagulation assays.

• Targeted SPP1 Suppression in TAMs Reduces Tumor Burden

  2026-07-13

  This study introduces a phenotypic screening approach to identify small molecule modulators that suppress SPP1 in tumor-associated macrophages, a key pro-tumorigenic cell type. The resulting nanoformulation effectively reduced tumor size in vivo, highlighting a promising strategy for targeted cancer immunotherapy.

• Carbapenemase Genes in Enterobacter cloacae: Dynamics and Re

  2026-07-13

  This study provides a detailed molecular epidemiology of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) isolated from hospitals in Guangdong, China, during the COVID-19 pandemic. Key findings reveal extensive multidrug resistance driven by plasmid- and chromosome-borne CEGs, with significant implications for infection control and antimicrobial resistance research.

• RSL3 Glutathione Peroxidase 4 Inhibitor: Applied Workflows &

  2026-07-12

  Unlock robust ferroptosis induction and synthetic lethality in cancer research with RSL3, a benchmark glutathione peroxidase 4 inhibitor. This guide delivers actionable protocols, troubleshooting insights, and advanced application strategies for maximizing reproducibility and translational impact in oxidative stress and tumor biology studies.

• Targeting GOT1 With Ziprasidone Disrupts Redox in Pancreatic

  2026-07-10

  The referenced study demonstrates that ziprasidone, a non-competitive inhibitor of GOT1, disrupts glutamine metabolism and redox homeostasis in pancreatic ductal adenocarcinoma (PDAC) cells, resulting in suppressed tumor proliferation. These findings highlight GOT1 as a metabolic vulnerability in PDAC and suggest new strategies for targeting tumor cell redox regulation.

• G-1: Selective GPR30 Agonist for Targeted Cardiovascular and

  2026-07-09

  G-1 (CAS 881639-98-1), a highly selective GPR30 agonist from APExBIO, enables precise modulation of rapid estrogen signaling in cardiovascular and breast cancer models. This guide integrates latest workflow enhancements, troubleshooting insights, and pivotal findings from recent literature to optimize G-1’s applied use in cell-based and in vivo research.

• Brefeldin A in Experimental ER Stress and Cancer Apoptosis R

  2026-07-09

  Brefeldin A (BFA) is a versatile ATPase inhibitor that revolutionizes ER stress modeling and apoptosis induction in cancer cell studies. This article details advanced workflows, protocol parameters, and troubleshooting strategies, drawing on recent breakthroughs in endothelial injury research and protein trafficking inhibition.

• SW033291: 15-PGDH Inhibitor Protocols for Regeneration Resea

  2026-07-08

  SW033291 is setting new standards as a potent 15-PGDH inhibitor, enabling precise elevation of prostaglandin E2 and accelerating tissue and muscle regeneration. This guide covers experimental workflows, troubleshooting, and the latest evidence on muscle repair during GLP-1 RA–induced weight loss.

• Testosterone Bounce as a Prognostic Biomarker in Degarelix T

  2026-07-08

  A recent multi-center study demonstrates that testosterone 'bounce'—a transient rise above 20 ng/dL after nadir—predicts improved overall and cancer-specific survival in prostate cancer patients treated with the GnRH receptor antagonist Degarelix acetate. This finding highlights the clinical value of dynamic testosterone monitoring beyond traditional PSA-based assessments.

• Filipin III: Advancing Cholesterol Mapping for MASLD Researc

  2026-07-07

  Explore how Filipin III, a polyene macrolide antibiotic, enables high-resolution visualization of membrane cholesterol, empowering translational researchers to dissect cholesterol homeostasis in metabolic dysfunction-associated steatotic liver disease (MASLD). This thought-leadership article delivers mechanistic insights, strategic protocol guidance, and a roadmap for leveraging Filipin III in next-generation metabolic disease research, integrating the latest findings on Caveolin-1’s role in cholesterol regulation.

• Hexa His Tag Peptide: Precision in 6X His Protein Purificati

  2026-07-07

  Hexa His tag peptide streamlines the immunoprecipitation of His-tagged proteins, delivering clean, antibody-free elution and high solubility for robust workflows. From protein purification to advanced interaction studies, this tool from APExBIO stands out for reproducibility, speed, and minimal contamination.

• Nonivamide: Capsaicin Analog for TRPV1 Cancer & Inflammation

  2026-07-06

  Nonivamide (Capsaicin Analog) unlocks highly selective TRPV1 activation for advanced cancer and neuroimmune research, offering reproducible anti-proliferative and anti-inflammatory workflows. Its unique solubility, validated apoptotic pathways, and translational efficacy in tumor and inflammation models set it apart as a cornerstone for oncology and immunology labs.

15643 records 1/1043 page Next 12345 下5页 Last page